Macrogenics Inc (MGNX)
3.70
-0.01
(-0.27%)
USD |
NASDAQ |
Nov 05, 11:24
Macrogenics Cash from Financing (Quarterly): 0.625M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.625M |
| March 31, 2024 | 0.248M |
| December 31, 2023 | 0.273M |
| September 30, 2023 | 49.91M |
| June 30, 2023 | 0.059M |
| March 31, 2023 | 100.12M |
| December 31, 2022 | 1.359M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.263M |
| March 31, 2022 | 0.037M |
| December 31, 2021 | 0.80M |
| September 30, 2021 | 18.97M |
| June 30, 2021 | 2.346M |
| March 31, 2021 | 100.66M |
| December 31, 2020 | 1.102M |
| September 30, 2020 | 74.06M |
| June 30, 2020 | 99.02M |
| March 31, 2020 | 0.162M |
| December 31, 2019 | 0.297M |
| September 30, 2019 | 0.037M |
| June 30, 2019 | 0.633M |
| March 31, 2019 | 119.00M |
| December 31, 2018 | 0.475M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.132M |
| June 30, 2018 | 103.76M |
| March 31, 2018 | 0.629M |
| December 31, 2017 | 0.359M |
| September 30, 2017 | 1.147M |
| June 30, 2017 | 33.73M |
| March 31, 2017 | 0.108M |
| December 31, 2016 | 0.492M |
| September 30, 2016 | 1.011M |
| June 30, 2016 | 0.127M |
| March 31, 2016 | 0.224M |
| December 31, 2015 | 0.25M |
| September 30, 2015 | 140.98M |
| June 30, 2015 | 0.17M |
| March 31, 2015 | 62.95M |
| December 31, 2014 | 0.222M |
| September 30, 2014 | 0.18M |
| June 30, 2014 | 0.238M |
| March 31, 2014 | 76.80M |
| December 31, 2013 | 85.02M |
| September 30, 2013 | 0.142M |
| June 30, 2013 | 0.6525M |
| March 31, 2013 | 0.0565M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2022
100.66M
Maximum
Mar 2021
23.70M
Average
0.80M
Median
Dec 2021
Cash from Financing (Quarterly) Benchmarks
| Zimmer Biomet Holdings Inc | -101.90M |
| Penumbra Inc | -100.55M |
| Apellis Pharmaceuticals Inc | 42.49M |
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 5.991M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -44.48M |
| Cash from Investing (Quarterly) | 47.44M |
| Free Cash Flow | -157.02M |
| Free Cash Flow Per Share (Quarterly) | -0.7264 |
| Free Cash Flow to Equity (Quarterly) | -45.52M |
| Free Cash Flow Yield | -68.11% |